Skip to content

In vivo characterization of allergen extracts - 2

In vivo characterization of allergen extracts - 2 - In vivo characterization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35402
Enrollment
25
Registered
2009-10-12
Start date
2010-04-13
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergie allergic reactions

Interventions

None listed

Sponsors

HAL Allergenen Lab
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who give a positive reaction on the skin prick test (sum of erythema diameters >

Exclusion criteria

Exclusion criteria: 1. Treatment with immunotherapy (IT) of the involved allergen during the last 5 years 2. The use of oral and/or local antihistamines in the last 4 days 3. The use of oral corticosteroids or mast cell stabilizers in the last 48 hours 4. Pregnancy 5. Lack of cooperation or severe psychological disorders 6. Negative control in the SPT sum of wheal diameters > 5 mm 7. Positive control in the SPT sum of erythema diameters * 30 mm

Design outcomes

Primary

MeasureTime frame
The test parameter is the sum of diameters of the erythema 20 minutes after intracutanous injection of the allergen extract dilution. The sum is determined by the sum of the longest diameter of the redness and the mid-point diameter perpendicular to the longest diameter. From the main study parameter the biological alergy units of the extract will be calculated.

Secondary

MeasureTime frame
No secondary parameters will be determined.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)